Impact of HMG-CoA reductase inhibitors for non-treated coronary segments.
Nishioka H, Shimada K, Kataoka T, Hirose M, Asawa K, Hasegawa T, Yamashita H, Ehara S, Kamimori K, Sakamoto T, Kobayashi Y, Yoshimura T, Yoshiyama M, Takeuchi K, Yoshikawa J.
Nishioka H, et al.
Osaka City Med J. 2004 Dec;50(2):61-8.
Osaka City Med J. 2004.
PMID: 15819300
Clinical Trial.